Tim Chan

497 total citations
20 papers, 343 citations indexed

About

Tim Chan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Tim Chan has authored 20 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Tim Chan's work include Prostate Cancer Treatment and Research (9 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Tim Chan is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Tim Chan collaborates with scholars based in China, Hong Kong and Singapore. Tim Chan's co-authors include Hung Huynh, Michaël Pollak, Kuen Chan, Darren M.C. Poon, Choon Kiat Ong, Chuan Young Ng, Paul Dorian, Henry Sze, Jamie Hutchison and Damon C. Scales and has published in prestigious journals such as Journal of Clinical Oncology, Endocrinology and Annals of Oncology.

In The Last Decade

Tim Chan

18 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tim Chan China	10	123	113	65	55	54	20	343
Kazım Şenol Türkiye	11	55 0.4×	62 0.5×	53 0.8×	39 0.7×	10 0.2×	36	377
Alexander Emmert Germany	11	17 0.1×	139 1.2×	28 0.4×	27 0.5×	21 0.4×	28	407
Mohamed Khalfallah Tunisia	10	17 0.1×	50 0.4×	25 0.4×	9 0.2×	52 1.0×	52	263
Yoshitaro Yoshida Japan	6	51 0.4×	30 0.3×	66 1.0×	20 0.4×	8 0.1×	12	270
Mahyar Mohammadifard Iran	9	21 0.2×	32 0.3×	30 0.5×	17 0.3×	15 0.3×	33	221
Jaya Paranilam United States	8	15 0.1×	34 0.3×	157 2.4×	56 1.0×	57 1.1×	14	401
Vladimir Djukić Serbia	10	24 0.2×	36 0.3×	14 0.2×	14 0.3×	18 0.3×	34	255
Wenxue Hu China	11	18 0.1×	71 0.6×	76 1.2×	23 0.4×	7 0.1×	35	336
Martin T. Yates United Kingdom	10	12 0.1×	84 0.7×	46 0.7×	11 0.2×	13 0.2×	24	302
Lianfeng Zhang China	9	11 0.1×	152 1.3×	60 0.9×	38 0.7×	15 0.3×	17	328

Countries citing papers authored by Tim Chan

Since Specialization

Citations

This map shows the geographic impact of Tim Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Chan more than expected).

Fields of papers citing papers by Tim Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Chan. The network helps show where Tim Chan may publish in the future.

Co-authorship network of co-authors of Tim Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Chan. A scholar is included among the top collaborators of Tim Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Chan. Tim Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chan, Kuen, et al.. (2023). A territory-wide real-world efficacy and toxicity analysis of abiraterone acetate versus docetaxel in 574 Asian patients with metastatic hormone-sensitive prostate cancer. Clinical Genitourinary Cancer. 22(1). e75–e85.e1. 5 indexed citations

Poon, Darren M.C., Kuen Chan, Tim Chan, et al.. (2022). Ethnic Pharmacogenomic Differences in the Management of Asian Patients with Metastatic Prostate Cancer. Cancers. 14(2). 407–407. 6 indexed citations

Poon, Darren M.C., Kuen Chan, Tim Chan, et al.. (2020). 219MO Real-world utilization pattern of bone-targeted agents for metastatic prostate cancer: Web-based questionnaire study by Hong Kong Society of Uro-Oncology (HKSUO). Annals of Oncology. 31. S1326–S1326.

Allan, Katherine S., Joel G. Ray, Peter Gozdyra, et al.. (2020). High risk neighbourhoods: The effect of neighbourhood level factors on cardiac arrest incidence. Resuscitation. 149. 100–108. 8 indexed citations

Poon, Darren M.C., et al.. (2020). Prevention of docetaxel-associated febrile neutropenia with primary granulocyte colony-stimulating factors (GCSF) in Chinese metastatic hormonal-sensitive (mHSPC) and castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 38(6_suppl). 72–72. 1 indexed citations

Reck, Martin, Federico Cappuzzo, Delvys Rodríguez‐Abreu, et al.. (2019). 127TiP PROPEL: A phase I/II trial of bempegaldesleukin (NKTR-214) in combination with pembrolizumab (pembro) in patients (pts) with advanced solid tumours. Annals of Oncology. 30. xi46–xi47. 1 indexed citations

Allan, Katherine S., Laurie J. Morrison, Arnold Pintér, et al.. (2019). Unexpected High Prevalence of Cardiovascular Disease Risk Factors and Psychiatric Disease Among Young People With Sudden Cardiac Arrest. Journal of the American Heart Association. 8(2). e010330–e010330. 25 indexed citations

Poon, Darren M.C., et al.. (2018). Survival Outcomes, Prostate-specific Antigen Response, and Tolerance in First and Later Lines of Enzalutamide Treatment for Metastatic Castration-resistant Prostate Cancer: A Real-World Experience in Hong Kong. Clinical Genitourinary Cancer. 16(5). 402–412.e1. 16 indexed citations

Cheskes, Sheldon, Sara Gray, Farida M. Jeejeebhoy, et al.. (2018). Incidence, outcomes and guideline compliance of out-of-hospital maternal cardiac arrest resuscitations: A population-based cohort study. Resuscitation. 132. 127–132. 15 indexed citations

10.

Teoh, Jeremy Yuen‐Chun, Darren M.C. Poon, Tim Chan, et al.. (2018). A Territory-wide, Multicenter, Age- and Prostate-specific Antigen-matched Study Comparing Chemohormonal Therapy and Hormonal Therapy Alone in Chinese Men With Metastatic Hormone-sensitive Prostate Cancer. Clinical Genitourinary Cancer. 17(1). e203–e208. 5 indexed citations

11.

Poon, Darren M.C., et al.. (2018). The survival outcome, prostate-specific antigen (PSA) response and risk of fatigue of enzalutamide as first- and later-line treatment options in patients with metastatic castration-resistant prostate cancer (mCRPC): The real-world experience.. Journal of Clinical Oncology. 36(6_suppl). 330–330. 1 indexed citations

12.

Buick, Jason E., Ian R. Drennan, Damon C. Scales, et al.. (2018). Improving Temporal Trends in Survival and Neurological Outcomes After Out-of-Hospital Cardiac Arrest. Circulation Cardiovascular Quality and Outcomes. 11(1). e003561–e003561. 87 indexed citations

13.

Poon, Darren M.C., et al.. (2018). Preliminary efficacy and tolerability of chemohormonal therapy in metastatic hormone‐naïve prostate cancer: The first real‐life experience in Asia. Asia-Pacific Journal of Clinical Oncology. 14(4). 347–352. 16 indexed citations

14.

Poon, Darren M.C., et al.. (2017). Differences in clinical outcome between docetaxel and abiraterone acetate as the first-line treatment in chemo-naïve metastatic castration-resistant prostate cancer patients with or without the ineligible clinical factors of the COU-AA-302 study. Prostate International. 6(1). 24–30. 10 indexed citations

15.

Poon, Darren M.C., et al.. (2016). Abiraterone acetate in metastatic castration-resistant prostate cancer – the unanticipated real-world clinical experience. BMC Urology. 16(1). 12–12. 44 indexed citations

16.

Huynh, H., et al.. (2001). Cloning and Characterization of a Novel Pregnancy-Induced Growth Inhibitor in Mammary Gland. Endocrinology. 142(8). 3607–3615. 34 indexed citations

17.

Chan, Tim, Gregory P. Mark, & Hung Huynh. (2001). Induction of mammary epithelial cell differentiation and inhibition of dimethylbenz(A)anthracene-induced mammary tumour by co-administration of a pure antiestrogen ICI 182,780 and testosterone enanthate. International Journal of Oncology. 19(2). 263–9. 2 indexed citations

18.

Huynh, Hung, et al.. (2001). Induction of UO-44 Gene Expression by Tamoxifen in the Rat Uterus and Ovary*. Endocrinology. 142(7). 2985–2995. 17 indexed citations

19.

Chan, Tim, Michaël Pollak, & Hung Huynh. (2001). Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.. PubMed. 7(8). 2545–54. 42 indexed citations

20.

Huynh, Hung, et al.. (2000). Modulation of transforming growth factor beta1 gene expression in the mammary gland by insulin-like growth factor I and octreotide.. International Journal of Oncology. 16(2). 277–81. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact